Dr. Lal PathLabs Limited has informed stock exchanges about an upcoming board meeting scheduled for January 30, 2026, where directors will review the company's third quarter performance and consider dividend distribution to shareholders.

Board Meeting Agenda

The board meeting will address two primary matters for the diagnostic services company. Directors will consider and approve the unaudited financial results for both standalone and consolidated operations covering the quarter and nine months ended December 31, 2025.

Dividend Consideration

The board will also deliberate on the declaration of a third interim dividend on equity shares for the financial year 2025-26. The company has indicated that the dividend declaration remains subject to board approval and may not be finalized depending on various factors considered during the meeting.

Regulatory Compliance

Dr. Lal PathLabs submitted this intimation to both the National Stock Exchange of India Limited and BSE Limited on January 23, 2026. The communication serves as a continuation of an earlier intimation dated December 29, 2025, which initially announced the board meeting for Q3FY26 results consideration.

The announcement was signed by Vinay Gujral, Company Secretary and Compliance Officer, ensuring proper regulatory disclosure requirements are met ahead of the scheduled board meeting.

Dr. Lal PathLabs Limited announced the launch of SOVAAKA, its new-age Diagnostic Experience Centre in Gurugram on January 6, 2026. The initiative represents a significant advancement in preventive healthcare, combining precision diagnostics with cutting-edge technology to deliver personalized wellness solutions.

Advanced Wellness Philosophy

Built on the philosophy of "Science Behind Wellness," SOVAAKA introduces a new standard in preventive and lifestyle healthcare. The centre brings together precision diagnostics, cutting-edge technology, and medical expertise to help individuals take proactive control of their health. This advanced wellness initiative goes beyond routine health checks to offer a deeply personalized diagnostics-led wellness experience.

Personalized Programs and Services

SOVAAKA offers doctor-designed programs customized to individual needs:

The centre integrates advanced diagnostics including high-sensitivity blood panels, genetic testing, AI-supported imaging, and seamlessly integrated digital health records. With end-to-end clinical report evaluation and tailored nutrition guidance, SOVAAKA delivers comprehensive understanding of health and wellness trajectory.

Technology and Equipment

The facility is equipped with state-of-the-art medical technology to ensure comprehensive health assessment:

The centre ensures fast turnaround times, comprehensive insights, and deeply personalized evaluation experiences for all patients.

Leadership Perspectives

(Hony) Brig. Dr. Arvind Lal, Executive Chairman of Dr. Lal PathLabs, emphasized the transformative nature of the initiative: "SOVAAKA marks a pivotal moment in the evolution of diagnostics — from disease detection to disease prediction. In a world where Non-Communicable Diseases (NCDs) or Lifestyle Diseases are affecting millions silently, science-led wellness and early screening play a transformative role."

Mr. Shankha Banerjee, CEO of Dr. Lal PathLabs, highlighted the comprehensive approach: "With SOVAAKA, we are reimagining how preventive healthcare is delivered. By bringing diagnostics, advanced imaging, and lifestyle-based programmes under one roof, we are creating a destination for individuals committed to investing in their long-term health."

Market Context and Strategic Positioning

The launch comes at a time when India is witnessing rapid growth in the preventive health and wellness segment. This growth is driven by increasing incidence of Non-Communicable Diseases, rising awareness, evolving lifestyles, and greater emphasis on early detection. With SOVAAKA, Dr. Lal PathLabs strengthens preventive care by offering comprehensive, evidence-backed solutions that empower individuals to understand their health better and act early.

SOVAAKA represents the premium wellness vertical from Dr. Lal PathLabs, merging diagnostic excellence, medical expertise, and AI technology to offer personalized, preventive, and predictive health experiences. The centre positions the company at the forefront of the evolving healthcare landscape, focusing on proactive health management rather than reactive treatment approaches.